ATE342270T1 - Pharmazeutische zusammensetzung enthaltend baicalin, chlorogensäure und forsythiaside in isolierter und gereinigter form und verfahren zur herstellung - Google Patents

Pharmazeutische zusammensetzung enthaltend baicalin, chlorogensäure und forsythiaside in isolierter und gereinigter form und verfahren zur herstellung

Info

Publication number
ATE342270T1
ATE342270T1 AT99901358T AT99901358T ATE342270T1 AT E342270 T1 ATE342270 T1 AT E342270T1 AT 99901358 T AT99901358 T AT 99901358T AT 99901358 T AT99901358 T AT 99901358T AT E342270 T1 ATE342270 T1 AT E342270T1
Authority
AT
Austria
Prior art keywords
chlorogenic acid
isolated
pharmaceutical composition
baicalin
present
Prior art date
Application number
AT99901358T
Other languages
English (en)
Inventor
Kai Jian Xu
Original Assignee
Kai Jian Xu
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kai Jian Xu filed Critical Kai Jian Xu
Application granted granted Critical
Publication of ATE342270T1 publication Critical patent/ATE342270T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/26—Acyclic or carbocyclic radicals, substituted by hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/35—Caprifoliaceae (Honeysuckle family)
    • A61K36/355—Lonicera (honeysuckle)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A61K36/539—Scutellaria (skullcap)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/63—Oleaceae (Olive family), e.g. jasmine, lilac or ash tree
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H3/00—Compounds containing only hydrogen atoms and saccharide radicals having only carbon, hydrogen, and oxygen atoms
    • C07H3/04—Disaccharides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Medical Informatics (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Botany (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Neurosurgery (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT99901358T 1998-01-12 1999-01-07 Pharmazeutische zusammensetzung enthaltend baicalin, chlorogensäure und forsythiaside in isolierter und gereinigter form und verfahren zur herstellung ATE342270T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US09/005,934 US6083921A (en) 1998-01-12 1998-01-12 Pharmaceutical compositions and method of using same

Publications (1)

Publication Number Publication Date
ATE342270T1 true ATE342270T1 (de) 2006-11-15

Family

ID=21718433

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99901358T ATE342270T1 (de) 1998-01-12 1999-01-07 Pharmazeutische zusammensetzung enthaltend baicalin, chlorogensäure und forsythiaside in isolierter und gereinigter form und verfahren zur herstellung

Country Status (7)

Country Link
US (1) US6083921A (de)
EP (1) EP1047439B1 (de)
AT (1) ATE342270T1 (de)
AU (1) AU765951B2 (de)
CA (1) CA2317453A1 (de)
DE (1) DE69933539T2 (de)
WO (1) WO1999034812A1 (de)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6290995B1 (en) * 2000-02-08 2001-09-18 Zhao Xinxian Plant drug for preventing cancer II
US20060143180A1 (en) * 2000-03-09 2006-06-29 Pkware, Inc. System and method for manipulating and managing computer archive files
CN1309399C (zh) * 2000-10-25 2007-04-11 国家中药制药工程技术研究中心 复方双黄连制剂及制备方法
US6632459B2 (en) * 2000-12-11 2003-10-14 Nutricia N.V. Chlorogenic acid and an analog thereof for immune system stimulation
US6455070B1 (en) 2001-02-15 2002-09-24 East Park Research, Inc. Composition for treating symptoms of influenza
US20030165588A1 (en) 2002-03-01 2003-09-04 Unigen Pharmaceuticals, Inc. Identification of free-B-ring flavonoids as potent COX-2 inhibitors
US7972632B2 (en) 2003-02-28 2011-07-05 Unigen Pharmaceuticals, Inc. Identification of Free-B-Ring flavonoids as potent COX-2 inhibitors
US7108868B2 (en) 2002-03-22 2006-09-19 Unigen Pharmaceuticals, Inc. Isolation of a dual cox-2 and 5-lipoxygenase inhibitor from acacia
US8945518B2 (en) * 2002-04-30 2015-02-03 Unigen, Inc. Formulation of dual eicosanoid system and cytokine system inhibitors for use in the prevention and treatment of oral diseases and conditions
US8034387B2 (en) * 2002-04-30 2011-10-11 Unigen, Inc. Formulation of a mixture of free-B-ring flavonoids and flavans for use in the prevention and treatment of cognitive decline and age-related memory impairments
EP1503778B1 (de) 2002-04-30 2009-08-05 Unigen Pharmaceuticals, Inc. Formulierung eines gemisches aus flavonoiden und flavanen mit freiem b ring als therapeutisches mittel
WO2003101446A1 (en) * 2002-05-31 2003-12-11 Council Of Scientific And Industrial Research A herbal molecule as potential anti-leukemic drug
DE10224456A1 (de) * 2002-06-03 2004-01-22 Beiersdorf Ag Verwendung von Jelängerjelieber-Blütenextrakt zur Herstellung kosmetischer oder dermatologischer Zubereitungen zur Prophylaxe und Behandlung von entzündlic hen Hautzuständen und/oder zum Hautschutz bei empfindlich determinierter Haut
JP2006519231A (ja) * 2003-02-26 2006-08-24 ユニゲン・ファーマシューティカルス・インコーポレーテッド 炭水化物誘導性疾患および状態の予防および処置用の製剤
BRPI0409179A (pt) 2003-04-04 2006-05-02 Unigen Pharmaceuticals Inc formulação de inibidores duplos de ciclooxigenase (cox) e lipoxigenase (lox) para cuidados com a pele de mamìferos
GB2388581A (en) * 2003-08-22 2003-11-19 Danisco Coated aqueous beads
JP4926707B2 (ja) * 2003-08-22 2012-05-09 ダニスコ エイ／エス 封入化抗菌材料
CA2537459A1 (en) * 2003-09-02 2005-03-10 Unigen Pharmaceuticals, Inc. Formulation of a mixture of free-b-ring flavonoids and flavans for use in the prevention and treatment of cognitive decline and age-related memory impairments
KR20050037102A (ko) * 2003-10-17 2005-04-21 한국 한의학 연구원 비만 억제용 조성물
US7605135B2 (en) * 2003-11-10 2009-10-20 The University Of Hong Kong Baicalin as a treatment for SARS infection
GB2425476A (en) * 2004-02-27 2006-11-01 Phynova Ltd Multi-herb medicament for the treatment of SARS
GB2425477B (en) * 2004-02-27 2008-04-23 Phynova Ltd Extract of Scutellaria for the treatment of RSV
US20100311827A1 (en) * 2006-07-21 2010-12-09 Mohsen Daneshtalab Chlorogenic acid derivatives and their use as anti-fungal agents
KR100761248B1 (ko) 2006-10-12 2007-10-04 주식회사 유니젠 대나무 및 황금 추출물을 유효성분으로 함유하는 아토피성피부염 치료를 위한 조성물
CN101209255B (zh) * 2006-12-28 2013-04-03 山东新时代药业有限公司 连翘酯苷注射制剂及其制备方法
MY184667A (en) * 2007-07-23 2021-04-15 Malaysian Palm Oil Board An antiviral composition
ES2962777T3 (es) 2007-11-15 2024-03-21 Amgen Inc Formulación acuosa de anticuerpos estabilizada por antioxidantes para la administración parenteral
CA2786169C (en) * 2009-12-30 2018-09-25 Allan Sik-Yin Lau Materials and methods for prevention and treatment of viral infections
CN102526208A (zh) * 2010-12-16 2012-07-04 四川科伦药物研究有限公司 一种双黄连泡腾片及其制备方法
CN103102270A (zh) * 2011-11-09 2013-05-15 安康市天源植物提取有限公司 一种绿原酸的制取方法
KR101182582B1 (ko) * 2012-04-27 2012-09-18 주식회사 휴온스 활성성분이 증대된 금은화 정제물을 제조하는 제조방법 및 이를 함유한 패혈증 및 패혈성 쇼크의 치료 및 예방용 조성물
KR101438332B1 (ko) 2013-09-05 2014-09-04 경희대학교 산학협력단 포시티아사이드-에이를 포함하는 탈모방지 또는 발모촉진용 조성물
CN104950063B (zh) * 2015-06-19 2017-03-01 广西壮族自治区梧州食品药品检验所 银黄颗粒中绿原酸含量测定方法
CN105675784B (zh) * 2016-01-26 2018-08-14 中国医学科学院肿瘤医院 Uplc-ms/ms法测定人血浆和尿液中绿原酸的浓度
CN108452012B (zh) * 2017-02-20 2021-04-06 国药集团广东环球制药有限公司 三黄片黄芩浸膏粉的制备方法
CN110151821B (zh) * 2019-05-09 2021-08-17 中山市恒生药业有限公司 一种银黄颗粒及其制备方法
CN110812531B (zh) * 2019-11-12 2022-08-26 上海交通大学医学院附属第九人民医院 复合材料及其制备方法和在脱钙骨基质支架中的应用
CN113209164B (zh) * 2020-02-06 2023-01-20 中国科学院上海药物研究所 黄芩、连翘、金银花主要成分及其组合物在抗冠状病毒中的应用
US20210369753A1 (en) * 2020-05-27 2021-12-02 Brilliant Lab LLC Nutrient composition able to inhibit quorum sensing
CN112946113B (zh) * 2021-02-01 2022-09-30 湖北医药学院 一种鉴别道地药材十堰连翘基源的方法
CN114586980A (zh) * 2022-03-11 2022-06-07 安徽黑娃食品科技有限公司 一种金银花提取物的制备方法及其在花生中的应用
CN115990187B (zh) * 2022-12-07 2024-02-06 北京中医药大学 一种用于改善阿尔茨海默病的中药提取物及其应用

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2224807A (en) * 1936-12-24 1940-12-10 Winthrop Chem Co Inc Glucosides of polyhydroxy-flavones and polyhydroxy-flavanones
US2425291A (en) * 1944-03-03 1947-08-05 Fruit Growers Exchange Ca Alkylated chalcone derivatives and methods of preparing the same
US2727890A (en) * 1953-03-02 1955-12-20 Simon H Wender Synthesis of an aldohexoside of a flavonol
US3700775A (en) * 1970-09-11 1972-10-24 Luigi Turbanti Choleretic activity
US4124724A (en) * 1975-12-08 1978-11-07 Agoro John W Crystalline caffeic acid derivatives and compositions and method for treating snakebite
IT1098309B (it) * 1978-06-02 1985-09-07 Snam Progetti Processo per la preparazione di isolato proteico da farina di girasole
JPS5562004A (en) * 1978-11-02 1980-05-10 Kureha Chem Ind Co Ltd Control agent against plant viral disease
NZ193316A (en) * 1979-04-10 1984-07-31 Hoffmann La Roche 3-alkoxyflavone derivatives and pharmaceutical compositions
DE3070086D1 (en) * 1979-12-03 1985-03-14 Kitasato Inst A process for preparing substances having interferon inducing activity
US4465673A (en) * 1983-01-10 1984-08-14 Yasuo Tanaka Pentagalloylglucose antiviral composition
JPS60243016A (ja) * 1984-05-17 1985-12-03 Tsumura Juntendo Inc 抗インフルエンザウイルス剤
DK17885D0 (da) * 1985-01-14 1985-01-14 Karlsson Karl Anders Antiviralt middel
DE3603574C1 (de) * 1986-02-06 1987-07-23 Ergo Forschungsgmbh Verfahren zur Gewinnung von Chlorogensaeure
ATE87204T1 (de) * 1987-12-10 1993-04-15 Tsumura & Co Anti-retrovirales arzneimittel.
JP2974370B2 (ja) * 1990-05-11 1999-11-10 社団法人北里研究所 シアリダーゼ阻害剤
US5178865A (en) * 1990-06-19 1993-01-12 Cedars-Sinai Medical Center Chinese herbal extracts in the treatment of hiv related disease in vitro
US5380916A (en) * 1990-11-02 1995-01-10 University Of Florida Method for the isolation and purification of taxane derivatives
US5478579A (en) * 1991-02-06 1995-12-26 Biodyn Medical Research, Inc. Method for treatment of osteoporosis
US5411733A (en) * 1992-04-27 1995-05-02 Hozumi; Toyoharu Antiviral agent containing crude drug
CN1089848A (zh) * 1993-01-15 1994-07-27 哈尔滨中药四厂 双黄连胶囊及其制备方法
CN1090185A (zh) * 1993-01-20 1994-08-03 哈尔滨中药四厂 双黄连口服液及其制备方法
CN1117851A (zh) * 1994-01-07 1996-03-06 山东中医学院 银黄含片及其制备工艺
CN1154246A (zh) * 1996-01-09 1997-07-16 李宏 一种抗菌抗病毒药物的组方

Also Published As

Publication number Publication date
EP1047439A1 (de) 2000-11-02
AU765951B2 (en) 2003-10-02
DE69933539D1 (de) 2006-11-23
WO1999034812A1 (en) 1999-07-15
CA2317453A1 (en) 1999-07-15
DE69933539T2 (de) 2007-07-05
EP1047439B1 (de) 2006-10-11
AU2107599A (en) 1999-07-26
US6083921A (en) 2000-07-04

Similar Documents

Publication Publication Date Title
ATE342270T1 (de) Pharmazeutische zusammensetzung enthaltend baicalin, chlorogensäure und forsythiaside in isolierter und gereinigter form und verfahren zur herstellung
DE60206474D1 (de) Prozess zur herstellung eines matrin enthaltenden pflanzenextrakts
Kuppusamy et al. Structure-activity studies of flavonoids as inhibitors of hyaluronidase
WO2002060379A3 (en) Composition comprising extracts of flos lonicerae, fructus forsythiae and radix scutellariae, uses and preparation thereof
PT906761E (pt) Metodo de preparacao e utilizacao de produtos fitoquimicos
Lee et al. Antioxidative activities of Korean medicinal plants
NZ284192A (en) Plant extract from the genus vaccinium with bacterial anti-adhesive activity and medicinal compositions
AU4200501A (en) Methods for making plants tolerant to glyphosate and compositions thereof
DE69836548D1 (de) Hefeextraktzusammensetzung, hefe zur herstellung derselben und verfahren zur herstellung einer hefeextraktzusammensetzung
CA2371896A1 (en) Method of increasing the content of flavonoids and phenolic substances in plants
WO2001091764A3 (en) Extracts from spermatophyte plants with immunomodulating activity
CA2352676A1 (en) Composition and method for treatment of symptoms associated with insufficient estrogen production
DE60115031D1 (de) Spermatophyte pflanzenextrakte mit antitumoraler wirkung
AU2003289535A1 (en) Anti-obesity ingretients from medicinal plants and their composittion
DE60333586D1 (de) Medikament mit epimedium-extrakt zur behandlung vo
AU2001269589A1 (en) Process for preparing composition comprising medicinal herb extract for preventing and curing arthritis and composition thereof
WO2003030822A3 (en) Pharmaceutical composition having prophylactic effects on lamivudine-related disease relapse and drug resistance and methods of using the same
RU93032711A (ru) Гепатозащитное средство и способ его получения
AU2003210162A1 (en) Skin-lightening composition
KR100364684B1 (en) Composition containing plant extract for promoting and maintaining erection
QIAN et al. Study on changing rules for total flavonoids and total terpene lactones in Ginkgo biloba leaves at different ages of tree and collecting seasons
HUP0101197A3 (en) Combined plant coagulate composition, process for producing thereof and its use
AU3151799A (en) Use of at least a plant extract of the compositae family, such as the genus bellis
Melnyk et al. HPTLC analysis of lime flowers (Tiliae flos)
UA35801A (uk) Збір лікарських рослин для нормалізації психічного стану дітей

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties